USPTO serial 79437200
KYONGBO
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- TMO LAW OFFICE 122
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with KYONGBO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Miriam D. Trudell
Miriam D. Trudell Davis Graham & Stubbs LLP3400 Walnut Street, Suite 700Denver, CO 80205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | harmaceuticals for antibiotics, antifungal preparations, anti-viral agents, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating hypertension, antihypertensives preparations, lipid lowering agents, antithrombotic preparation gastro-intestinal treatment preparations, analgesics, anti-inflammatory preparations, antiallergic medicines, pharmaceutical preparations for treating allergic rhinitis, asthma treatment preparations, pharmaceutical preparations for the treatment of rhinitis, preparations for the treatment of osteoporosis, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations for treating peripheral nervous system disorders, pharmaceutical preparations for the prevention of disorders of the nervous system, cardiovascular pharmaceutical preparations, anti-cancer preparations, local anesthetics preparations, sedatives preparations, dermatological pharmaceutical preparation, muscle relaxants preparations, hepatitis vaccine; pharmaceutical preparations for the treatment of the digestive system; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of the circulatory system; pharmaceutical preparations for the prevention of diseases of the respiratory system; pharmaceutical preparations for the treatment of disorders of the genitourinary system; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of Parkinson's disease; preparations for treatment of hepatitis; pharmaceutical for the treatment of erectile dysfunction; dietary supplement drinks; nutritional supplements; therapeutic drugs and agents in the nature of therapeutic pharmaceutical and agents for treating infectious diseases, skeletal and muscular disorders, cardiovascular and circulatory diseases, nervous system diseases, ocular disorders, respiratory diseases, gastrointestinal diseases, endocrine diseases, kidney diseases, hormonal diseases, and oncological diseases and disorders, pharmaceutical preparations for the treatment of musculoskeletal disorders, preparations for the treatment of hypercholesteremia; pharmaceutical agents affecting metabolism; vitamin and mineral supplements; medicinal healthcare preparations for supporting nutritional balance and overall well-being, namely, vitamin preparations, multivitamin preparations, nutritional supplements, dietary and nutritional supplements, protein dietary supplements, nutritional supplement energy bars, and powdered nutritional supplement drink mixes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes; nutraceuticals for use as a dietary supplement | ACTIVE | — |
| 035 | Wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceutical preparations for health care; retail store services featuring pharmaceutical preparations for health care; wholesale store services featuring dietary supplement drinks; retail store services featuring dietary supplement drinks; wholesale store services featuring nutritional supplements; retail store services featuring nutritional supplements; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; administrative processing of purchase orders; promoting the goods and services for others by means of operating an on-line comprehensive shopping mall with links to the retail websites for others; business intermediary services relating to mail order by telecommunications, namely, services featuring pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 11, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 11, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 14, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 14, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 21, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 21, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |